الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 226 |  |  |
| | | from | 226 | | |
Abstract
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. It is estimated that approximately 180 - 200 million individuals of the world population, are chronically infected with HCV. Egypt has among the world’s highest prevalence rates of HCV. While the physical consequences of chronic hepatitis C constitute a significant global public health problem, the psychological burden experienced by those suffering from chronic hepatitis C is also considerable. Depression is one of the most important complications during antiviral treatment of chronic hepatitis C infection. Furthermore, psychological co morbidities are one of the primary influences in the diminished quality of life experienced by chronic hepatitis C patients.Aim: The main purpose of the present study is to evaluate the impact of psychosocial intervention on the quality of life in patients with chronic hepatitis C virus infection. Method: This is quasi experimental research design carried out at the Center of liver and treatment for hepatic viruses by interferon at International Mansoura Hospital in Dakahlia governorate. The subjects of this study composed of 200 patients. Results: More than one third of the study and control group were in the age group of 30 to less than 40 years, with a mean age of 39.0±2.1 years and 41.0±2.3 years respectively. Statistical significant differences were found between total quality of life mean scores of the study and control groups immediately post, and two months after program implementation. Conclusion: The present study proved that, knowledge level, way of coping, feeling of stigma, quality of life and depression improved significantly in the study group after psychosocial intervention compared to the control group. So it is recommended to All patients with hepatitis C undergoing antiviral therapy should be counseled and encouraged to participate in educational programs at the time of diagnosis to reduce unnecessary behavioral changes and stigmatization perceptions to improve quality of life.